Point72 Middle East FZE »

Kymera Therapeutics shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $627k 25k 25.46

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Kymera Therapeutics

Baker Bros. Advisors
Atlas Venture Life Science Advisors
T. Rowe Price Associates
BVF
Wellington Management Company
Vanguard Group
FMR
venBio Select Advisor
BlackRock
Artal Group
Redmile Group
Geode Capital Management
Aquilo Capital Management
Goldman Sachs Group
Deer Management

View all funds holding Kymera Therapeutics